Several other equities research analysts have also weighed in on NTR. UBS Group reissued a buy rating on shares of Nutrien in a report on Wednesday, January 3rd. Sanford C. Bernstein began coverage on Nutrien in a research note on Wednesday, January 3rd. They issued an outperform rating for the company. BMO Capital Markets began coverage on Nutrien in a research note on Wednesday, January 3rd. They issued a market perform rating and a $54.00 target price for the company. Cowen restated an outperform rating and issued a $60.00 target price on shares of Nutrien in a research note on Thursday, January 4th. Finally, Macquarie began coverage on Nutrien in a research note on Friday, January 5th. They issued an outperform rating and a $59.00 target price for the company. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. Nutrien has an average rating of Buy and a consensus target price of $58.38.
Shares of Nutrien (NYSE NTR) opened at $46.81 on Wednesday. Nutrien has a twelve month low of $40.41 and a twelve month high of $56.18. The firm has a market capitalization of $15,748.03, a PE ratio of 37.49, a P/E/G ratio of 1.91 and a beta of 0.43. The company has a quick ratio of 0.50, a current ratio of 0.99 and a debt-to-equity ratio of 0.44.
Nutrien Ltd. produces and distributes potash, nitrogen, and phosphate products for agricultural, industrial, and feed customers worldwide. It offers potash crop feed, fertilizer, industrial, metal finishing, and purified acid products, as well as blends. The company is also involved in the retail operations that serve growers in seven countries across three continents.
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.